Meningotheliomatosis

Meningotheliomatosis is a rare cancer characterized by multiple tumors of the pia mater (meningiomas).

Tumors arise from meningeal endothelial cells lining the inner surface of the skull and spinal canal. Meningotheliomatosis can affect both the dura mater and the pia mater.

The disease progresses slowly and remains asymptomatic for a long time. The first signs appear when there is compression by tumors of the brain or spinal cord. These are headaches, dizziness, confusion, convulsions, numbness of the limbs.

Diagnosis is based on neuroimaging - MRI or CT of the brain. Treatment is surgical or radiation aimed at removing or reducing tumors. The prognosis depends on the location and size of the tumors.

Thus, meningotheliomatosis is a serious meningeal cancer that requires active treatment after diagnosis. Timely diagnosis and therapy improves the prognosis for patients.

Meningothelioma is a rare disease characterized by the formation of tumors from endothelial cells. These tumors can be found in various parts of the body, including the brain, lungs, liver and kidneys.

Meningothelioma of the brain is the most common form of this disease. It can occur at any age, but is most common in people over 40 years of age. Symptoms of brain meningothelioma may include headache, nausea, vomiting, blurred vision and memory loss.

Treatment for meningothelioma depends on its size and location. In some cases, surgical removal of the tumor may be required. In other cases, radiation therapy or chemotherapy may be used.

The main way to prevent meningothelioma is to prevent cardiovascular diseases and control blood cholesterol levels. It is also important to lead a healthy lifestyle, eat right and be physically active.